AGRICULTURE
Global CRISPR Gene Editing Market - Industry Trends and Forecast to 2032
REPORT OVERVIEW
Global CRISPR Gene Editing Market, By Type (CRISPR Products and CRISPR Services), Application (Agriculture, Biomedical, Industrial, Genome Engineering, Disease Models, Functional Genomics, and Others), End User (Academic Institutes and Research Centers, Biotechnology Companies, Contract Research Organizations (CROs), Pharmaceutical and Biopharmaceutical Companies, and Others), Region (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2032.
Market Insights
The global CRISPR gene editing market size is valued to be USD 1.54 billion in 2023 and is expected to reach USD 12.11 billion by 2032, and it is expected to register a CAGR of 31.23% over the forecast period 2024-2032.
CRISPR gene editing is a potent method for modifying an organism's DNA. It is an acronym for "Clustered Regularly Interspaced Short Palindromic Repeats" and Cas9 (CRISPR-associated protein 9). CRISPR-Cas9 is based on bacteria's natural defense system, which defends them from viruses. Scientists have modified this method to cut genes at particular points along the genome, allowing them to insert or remove genetic material.
CRISPR gene editing represent a new frontier in crop science, offering unprecedented opportunities to enhance crop yield, resilience, and nutritional value. The adoption of these technologies is growing rapidly, driven by their potential to address global food security challenges and promote sustainable agriculture. However, it is essential to navigate the ethical and regulatory landscape carefully to ensure that the benefits are equitably distributed and that environmental impacts are minimized.
As the field continues to evolve, ongoing research and innovation will unlock new possibilities for gene editing in agriculture. By embracing these advancements and fostering global collaboration, we can harness the full potential of CRISPR to create a more resilient and sustainable food system for future generations.
The respective global report analyses market trends, consumer behaviour and industry dynamics to guide towards entry into new markets with ease. Also, it assists in tailoring market specific and related products and services to meet the needs, preferences, and expectations of target audience by delving into their psychology. The report also specializes with comprehensive and extensive competitive analysis which offers useful insights into competitor strengths, weaknesses, opportunities, and threats. The respective report offers exclusive insights into the potential impact of disruptive developments and technologies that are expected to completely transform corporate operations. The context includes tailor-made research solutions to create a stronger footprint in their particular industries thereby offering dedicated customized solutions according to the client needs which helps in addressing unique business challenges with more simplified and efficient decision-making solutions.
Market Dynamics
DRIVERS
- Rising prevalence of chronic diseases
- Surging public and private investments
RESTRAINTS
- High costs associated with CRISPR therapies
- Ethical concerns and regulatory hurdles
OPPORTUNITIES
- Increasing government & private funding
- Technological advancements
CHALLENGES
- Limited off-the-shelf delivery systems
- Bioinformatic challenges
SEGMENTATION
- Type
- CRISPR Products
- CRISPR kits & Enzymes
- CRISPR Libraries
- Others
- CRISPR Services
- gRNA Design & Vector Construction
- Cell Line Engineering
- Screening Services
- Others
- Application
- Agriculture
- Biomedical
- Industrial
- Genome Engineering
- Disease Models
- Functional Genomics
- Others
- End User
- Academic Institutes and Research Centers
- Biotechnology Companies
- Contract Research Organizations (CROs)
- Pharmaceutical and Biopharmaceutical Companies
- Others
The respective global report is completely customizable specific to regions (North America, Europe, Asia-Pacific, South America, Middle East and Africa), countries, segments, and key players as per the client requirements.
REGIONAL SEGMENTATION
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- The Netherlands
- Belgium
- Turkey
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Singapore
- Malaysia
- Australia
- Thailand
- Philippines
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Chile
- Colombia
- Rest of South America
- Middle East and Africa
- Kingdom of Saudi Arabia
- South Africa
- U.A.E.
- Egypt
- Rest of Middle East and Africa
KEY MARKET PLAYERS
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Agilent Technologies Inc.
- Genscript Biotech Corporation
- CRISPR Therapeutics AG
- Editas Medicine
- Intellia Therapeutics Inc.
- Beam Therapeutics Inc.
- Caribou Biosciences Inc.
- Lonza Group Ltd.
Table OF CONTENTS
- SECTION 1 - INTRODUCTION
- 1.1 Taxonomy
- 1.2 Market Overview
- 1.3 Currency and Limitations
- 1.3.1 Currency
- 1.3.2 Limitations
- 1.4 Key Competitors
- SECTION 2 - RESEARCH METHODOLOGY
- 2.1 Research Approach
- 2.2 Data Collection and Validation
- 2.2.1 Secondary Research
- 2.2.2 Primary Research
- 2.3 Market Assessment
- 2.3.1 Market Size Estimation
- 2.3.2 Bottom-up Approach
- 2.3.3 Top-down Approach
- 2.3.4 Growth Forecast
- 2.4 Market Study Assumptions
- 2.5 Data Sources
- SECTION 3 - EXECUTIVE SUMMARY
- 3.1 Global CRISPR Gene Editing Market, by Type
- 3.2 Global CRISPR Gene Editing Market, by Application
- 3.3 Global CRISPR Gene Editing Market, by End User
- 3.4 Global CRISPR Gene Editing Market, by Geography
- 3.5 Market Position Grid
- SECTION 4 - PREMIUM INSIGHTS
- 4.1 Regulatory Framework
- 4.1.1 Standards
- 4.1.2 Regulatory Landscape
- 4.2 Value Chain Analysis
- 4.3 Supply Chain Analysis
- 4.4 COVID-19 Impact
- 4.5 Russia-Ukraine War Impact
- 4.6 PORTER's Five Force Analysis
- 4.7 PESTLE Analysis
- 4.8 SWOT Analysis
- 4.9 Go to Market Strategy
- 4.10 Opportunity Orbit
- 4.11 Multivariate Modelling
- 4.12 Pricing Analysis
- SECTION 5 - MARKET DYNAMICS
- 5.1 Trends
- 5.1.1 Growing awareness of genetic disorders
- 5.1.2 Expanding applications beyond therapeutics
- 5.1.3 Trend 3
- 5.2 Drivers
- 5.2.1 Rising prevalence of chronic diseases
- 5.2.2 Surging public and private investments
- 5.2.3 Driver 3
- 5.2.4 Driver 4
- 5.3 Restraints
- 5.3.1 High costs associated with CRISPR therapies
- 5.3.2 Ethical concerns and regulatory hurdles
- 5.3.3 Restraint 3
- 5.4 Opportunities
- 5.4.1 Increasing government & private funding
- 5.4.2 Technological advancements
- 5.4.3 Opportunity 3
- 5.4.4 Opportunity 4
- 5.5 Challenges
- 5.5.1 Limited off-the-shelf delivery systems
- 5.5.2 Bioinformatic challenges
- 5.5.3 Challenge 3
- SECTION 6 - GLOBAL CRISPR GENE EDITING MARKET, BY TYPE
- 6.1 Type Summary
- 6.2 Market Attractive Index
- 6.3 Global CRISPR Gene Editing Market, by Type (2019-2032)
- SECTION 7 - GLOBAL CRISPR GENE EDITING MARKET, BY APPLICATION
- 7.1 Application Summary
- 7.2 Market Attractive Index
- 7.3 Global CRISPR Gene Editing Market, by Application (2019-2032)
- SECTION 8 - GLOBAL CRISPR GENE EDITING MARKET, BY END USER
- 8.1 End User Summary
- 8.2 Market Attractive Index
- 8.3 Global CRISPR Gene Editing Market, by End User (2019-2032)
- SECTION 9 - GLOBAL CRISPR GENE EDITING MARKET, BY GEOGRAPHY
- 9.1 Regional Summary
- 9.2 Market Attractive Index
- 9.3 Global CRISPR Gene Editing Market, by Geography (2019-2032)
- SECTION 10 - NORTH AMERICA CRISPR GENE EDITING MARKET
- 10.1 North America Summary
- 10.2 Market Attractive Index
- 10.3 North America CRISPR Gene Editing Market, by Type (2019-2032)
- 10.4 North America CRISPR Gene Editing Market, by Application (2019-2032)
- 10.5 North America CRISPR Gene Editing Market, by End User (2019-2032)
- 10.6 North America CRISPR Gene Editing Market, by Country (2019-2032)
- 10.6.1 U.S.
- 10.6.2 Canada
- 10.6.3 Mexico
- 10.6.4 Rest of North America
- SECTION 11 - EUROPE CRISPR GENE EDITING MARKET
- 11.1 Europe Summary
- 11.2 Market Attractive Index
- 11.3 Europe CRISPR Gene Editing Market, by Type (2019-2032)
- 11.4 Europe CRISPR Gene Editing Market, by Application (2019-2032)
- 11.5 Europe CRISPR Gene Editing Market, by End User (2019-2032)
- 11.6 Europe CRISPR Gene Editing Market, by Country (2019-2032)
- 11.6.1 Germany
- 11.6.2 U.K.
- 11.6.3 France
- 11.6.4 Italy
- 11.6.5 Spain
- 11.6.6 Russia
- 11.6.7 The Netherlands
- 11.6.8 Belgium
- 11.6.9 Turkey
- 11.6.10 Rest of Europe
- SECTION 12 - ASIA-PACIFIC CRISPR GENE EDITING MARKET
- 12.1 Asia-Pacific Summary
- 12.2 Market Attractive Index
- 12.3 Asia-Pacific CRISPR Gene Editing Market, by Type (2019-2032)
- 12.4 Asia-Pacific CRISPR Gene Editing Market, by Application (2019-2032)
- 12.5 Asia-Pacific CRISPR Gene Editing Market, by End User (2019-2032)
- 12.6 Asia-Pacific CRISPR Gene Editing Market, by Country (2019-2032)
- 12.6.1 China
- 12.6.2 India
- 12.6.3 Japan
- 12.6.4 South Korea
- 12.6.5 Singapore
- 12.6.6 Malaysia
- 12.6.7 Australia
- 12.6.8 Thailand
- 12.6.9 Philippines
- 12.6.10 Rest of Asia-Pacific
- SECTION 13 - SOUTH AMERICA CRISPR GENE EDITING MARKET
- 13.1 South America Summary
- 13.2 Market Attractive Index
- 13.3 South America CRISPR Gene Editing Market, by Type (2019-2032)
- 13.4 South America CRISPR Gene Editing Market, by Application (2019-2032)
- 13.5 South America CRISPR Gene Editing Market, by End User (2019-2032)
- 13.6 South America CRISPR Gene Editing Market, by Country (2019-2032)
- 13.6.1 Brazil
- 13.6.2 Argentina
- 13.6.3 Chile
- 13.6.4 Colombia
- 13.6.5 Rest of South America
- SECTION 14 - MIDDLE EAST AND AFRICA CRISPR GENE EDITING MARKET
- 14.1 Middle East and Africa Summary
- 14.2 Market Attractive Index
- 14.3 Middle East and Africa CRISPR Gene Editing Market, by Type (2019-2032)
- 14.4 Middle East and Africa CRISPR Gene Editing Market, by Application (2019-2032)
- 14.5 Middle East and Africa CRISPR Gene Editing Market, by End User (2019-2032)
- 14.6 Middle East and Africa CRISPR Gene Editing Market, by Country (2019-2032)
- 14.6.1 Kingdom of Saudi Arabia
- 14.6.2 South Africa
- 14.6.3 U.A.E.
- 14.6.4 Egypt
- 14.6.5 Rest of Middle East and Africa
- SECTION 15 - COMPANY SHARE ANALYSIS
- 15.1 Global CRISPR Gene Editing Market, Company Share Analysis
- 15.2 North America CRISPR Gene Editing Market, Company Share Analysis
- 15.3 Europe CRISPR Gene Editing Market, Company Share Analysis
- 15.4 Asia-Pacific CRISPR Gene Editing Market, Company Share Analysis
- SECTION 16 - COMPANY PROFILES
- 16.1 Thermo Fisher Scientific Inc.
- 16.1.1 Company Snapshot
- 16.1.2 Financial Overview
- 16.1.3 Product Portfolio
- 16.1.4 Recent Developments
- 16.2 Merck KGaA
- 16.2.1 Company Snapshot
- 16.2.2 Financial Overview
- 16.2.3 Product Portfolio
- 16.2.4 Recent Developments
- 16.3 Agilent Technologies Inc.
- 16.3.1 Company Snapshot
- 16.3.2 Financial Overview
- 16.3.3 Product Portfolio
- 16.3.4 Recent Developments
- 16.4 Genscript Biotech Corporation
- 16.4.1 Company Snapshot
- 16.4.2 Financial Overview
- 16.4.3 Product Portfolio
- 16.4.4 Recent Developments
- 16.5 CRISPR Therapeutics AG
- 16.5.1 Company Snapshot
- 16.5.2 Financial Overview
- 16.5.3 Product Portfolio
- 16.5.4 Recent Developments
- 16.6 Editas Medicine
- 16.6.1 Company Snapshot
- 16.6.2 Financial Overview
- 16.6.3 Product Portfolio
- 16.6.4 Recent Developments
- 16.7 Intellia Therapeutics Inc.
- 16.7.1 Company Snapshot
- 16.7.2 Financial Overview
- 16.7.3 Product Portfolio
- 16.7.4 Recent Developments
- 16.8 Beam Therapeutics Inc.
- 16.8.1 Company Snapshot
- 16.8.2 Financial Overview
- 16.8.3 Product Portfolio
- 16.8.4 Recent Developments
- 16.9 Caribou Biosciences Inc.
- 16.9.1 Company Snapshot
- 16.9.2 Financial Overview
- 16.9.3 Product Portfolio
- 16.9.4 Recent Developments
- 16.10 Lonza Group Ltd.
- 16.10.1 Company Snapshot
- 16.10.2 Financial Overview
- 16.10.3 Product Portfolio
- 16.10.4 Recent Developments
- SECTION 17 - RELATED REPORTS
- SECTION 18 - DISCLAIMER
RESEARCH METHODOLOGY
The research methodology employed in Uniprism Market Research involves four basic steps namely research and data collection, data pre-processing, modeling and forecasting, quality assurance and output.
RESEARCH AND DATA COLLECTION
A tripod model research technique is followed for research and data collection in which various approaches such as primary research, secondary research, and product mapping are considered.
Primary research basically involves the process of conducting personalized interviews with market related professionals of major market players, investors, distributors, vendors and many more.
The secondary research include data published by government, annual reports, press releases, investor presentations of companies, white papers, certified publications, annual manufacturing limit of the respective industries related to the market, production consumption analysis of certain products respective to the market and many more.
Below mention are few of the sources which we have considered while estimating the market size:
For instance,
- Research articles published on Technium
- Science and MDPI
- Research publications by government approved associations and societies
Product mapping means the process of mapping the list of products that a key player contributes to the market as well as estimating the revenue of those products in order to define the Global Company share analysis of the respective Global Company in global, regional, and country level markets.
DATA PRE-PROCESSING
The term "data pre-processing" refers to the collection of procedures and methods used to clean, modify, and make ready for analysis the raw data gathered during research and data collection. The completion of this phase is necessary to guarantee that the data are reliable, consistent, and appropriate for statistical analysis and other data-driven tasks. The data pre-processing ensures that the information gathered from research and data collection is comparable and expressed in standard units, by the integration of missing data pointers and algorithmic approaches.
MODELING AND FORECASTING
The process of developing mathematical, statistical, or computational representations of real-world occurrences or relationships is known as modelling. These models are intended to replicate and explain market interactions, interdependence, and dynamics. These models are used by Uniprism Market Research to acquire a better knowledge of numerous market characteristics such as customer preferences, pricing elasticity, competition dynamics, and more. Depending on the individual study aims, many types of models are utilized, such as regression models, econometric models, decision tree models, and machine learning models.
Forecasting is the process of predicting future market conditions, trends, and occurrences using past data and models. Forecasting is used by Uniprism Market Research to estimate future sales, demand for products or services, market growth, and other important performance metrics. Forecasting accurately can assist organizations in making educated decisions about resource allocation, pricing, inventory management, and marketing tactics.
We create standardized bottom-up or top-down models that scale by leveraging data science and machine learning technology. All our market models consider the unique market characteristics of each country. Forecasting is based on major market indicators and a combination of traditional methodologies, such as exponential smoothing, time series analysis, regression analysis, and more modern techniques such as machine learning algorithms are all forecasting methodologies. The method chosen is determined on the nature of the data and the specific forecasting aims.
QUALITY ASSURANCE AND OUTPUT
Quality assurance and output involves the process of validation, adjustments, further publications of key market indicators. Extensive plausibility and consistency tests are performed on derived time series to ensure the high degree of quality of our market analysis. This quality assurance procedure also includes rigorous inspection, validation, and editing by an experienced management team to assure the dependability of the published data.